The safety and efficacy of PDE5-inhibitors-vardenafil on treating diabetes mellitus erectile dysfunction: A protocol for systematic review and meta analysis

BACKGROUND: Diabetic mellitus erectile dysfunction (DMED) refers to erectile dysfunction (ED) secondary to diabetes. As people's lifestyle changes and the population ages, the incidence of DMED continues to increase. Many clinical trials have proven that PDE5-inhibitors-vardenafil has a signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jia, Li, Xiao, Dai, Heng-Heng, Wang, Ji-Sheng, Li, Hai-Song, Zhang, Xiao-Jun, Wang, Ping, Zhang, Dong, Zuo, Ling-Yan, Xie, Ning, Li, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940040/
https://www.ncbi.nlm.nih.gov/pubmed/31860994
http://dx.doi.org/10.1097/MD.0000000000018361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940040/
https://www.ncbi.nlm.nih.gov/pubmed/31860994
http://dx.doi.org/10.1097/MD.0000000000018361

Ejemplares similares